Search company, investor...

Compare Neuromonics vs Portaero

Customers evaluate the quality of Neuromonics's products using the following success metrics.

Overview

N

Neuromonics is based in United States

Neuromonics is an Australian company that has developed an FDA approved device for treatment of tinnitus over a six month process with 2 hours of use per day.

P

Portaero is based in United States

Portaero, in stealth mode, is a medical devices firm, developing a device for the treatment of COPD (Chronic obstructive pulmonary disease).

Country

United States
United States

Demo Video

Demo not available because Neuromonics has not claimed their profile.

Work for Neuromonics? Show off your product.

Demo not available because Portaero has not claimed their profile.

Work for Portaero? Show off your product.

Leadership

Eula Adams (Chief Executive Officer)

See all 4 people

Dave Plough (Chief Executive Officer)

Funding

Portaero last raised $11.8M on 7/7/2009.

Stage

Other Investors
Series B

Total Raised

$15.17M

Investors

Innovation Capital Limited and GBS Venture Partners

Versant Ventures, Aberdare Ventures

See all 3 investors

Product

Benefits

Products

Customers

Known Partners

Why They Buy

Information not available because Neuromonics has not claimed their profile.

Work for Neuromonics? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Neuromonics?

Claim your profile now.

Information not available because Portaero has not claimed their profile.

Work for Portaero? Claim your profile by submitting an Analyst Briefing. By submitting you can

Show your primary competitive advantage
Highlight your competitive differentiation
Show why customers evalute your products
Explain why customers choose your products and services

Work for Portaero?

Claim your profile now.